{"id":374212,"date":"2024-10-20T02:37:30","date_gmt":"2024-10-20T02:37:30","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-tir20416-2020\/"},"modified":"2024-10-26T04:35:12","modified_gmt":"2024-10-26T04:35:12","slug":"aami-tir20416-2020","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-tir20416-2020\/","title":{"rendered":"AAMI TIR20416 2020"},"content":{"rendered":"
The is an adoption of AAMI\/ISO TIR 20416<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | AAMI\/ISO TIR20416:2020; Medical devices\u2014Post-market surveillance for manufacturers <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Blank Page <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | AAMI Technical Information Report ANSI Registration <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Contents Page <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Background of AAMI adoption of ISO TR 20416 Ed.1. <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | Figure 1 \u2014 Inter-relationship of ISO TR 20416 with ISO 13485 and ISO 14971 standards <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 4 Purpose of post-market surveillance process <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | Figure 2 \u2014 Example schematic representation of post-market surveillance <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 5 Planning of post-market surveillance 5.1 General 5.2 Scope of the post-market surveillance plan <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 5.3 Objective of the post-market surveillance plan <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | Table 1 \u2014 Examples of post-market surveillance plan objectives. <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 5.4 Responsibilities and authorities Table 2 \u2014 Example of post-market surveillance resources allocation matrix. <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 5.5 Data collection 5.5.1 Data sources 5.5.2 Defining data collection methods <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 5.5.3 Developing the data collection protocol 5.6 Data analysis 5.6.1 General <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 5.6.2 Considerations concerning planning the data analysis 5.6.3 Methods for data analysis Table 3 \u2014 Examples of the objective and appropriate data analysis methods <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 5.7 Report on data analysis <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 5.8 Interface with other processes 6 Review of the post-market surveillance plan 6.1 Purpose of the review 6.2 Criteria <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 6.3 Review <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | Annex A (informative) Examples of data sources Table A.1 \u2014 Examples of data sources that can be used for post-market surveillance activities <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | Annex B (informative) Examples of data analysis methods B.1 General B.2 Overview table: data analysis methods <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | Table B.1 \u2014 Examples of data sources and suggested methods for data analysis B.3 Descriptive methods for trend analysis <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | Figure B.1 \u2014 Examples of types of changes identified using trend analysis <\/td>\n<\/tr>\n | ||||||
39<\/td>\n | Figure B.2 \u2014 Trending of monthly complaint rate B.4 Descriptive method: Bar charts <\/td>\n<\/tr>\n | ||||||
40<\/td>\n | Figure B.3 \u2014 Bar chart showing the number of reported complaints for three medical device variants 1, 2 and 3 B.5 Descriptive method, Pareto analysis <\/td>\n<\/tr>\n | ||||||
41<\/td>\n | Figure B.4 \u2014 Pareto diagram for complaint causes for implant instruments (product family) B.6 Qualitative techniques <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | Annex C (informative) Examples of post-market surveillance plans C.1 Example of a post-market surveillance plan for a surgical scalpel C.1.1 General C.1.2 Scope of the post-market surveillance plan C.1.3 Objective of the post-market surveillance plan C.1.4 Responsibilities and authorities <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | C.1.5 Data collection C.1.6 Data analysis C.1.7 Report on data analysis <\/td>\n<\/tr>\n | ||||||
45<\/td>\n | C.1.8 Review of the post-market surveillance plan C.2 Example of a post-market surveillance plan for a radiation therapy system C.2.1 General C.2.2 Scope of the post-market surveillance plan C.2.3 Objective of the post-market surveillance plan C.2.4 Responsibilities and authorities <\/td>\n<\/tr>\n | ||||||
46<\/td>\n | C.2.5 Data collection Table C.1 \u2014 Data collection and data analysis activities <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | C.2.6 Data analysis C.2.7 Report on data analysis C.2.8 Review of the post-market surveillance plan C.3 Example of a post-market surveillance plan for a drug eluting stent C.3.1 General C.3.2 Scope of the post-market surveillance plan <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | C.3.3 Objective of the post-market surveillance plan C.3.4 Responsibilities and authorities C.3.5 Data collection C.3.5.1 Passive\/reactive feedback C.3.5.2 Proactive feedback <\/td>\n<\/tr>\n | ||||||
49<\/td>\n | C.3.6 Data analysis C.3.6.1 General C.3.6.2 Post-market clinical follow-up studies <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | C.3.7 Report on data analysis C.3.8 Review of the post-market surveillance plan C.4 Example of a post-market surveillance plan for a blood glucose monitoring system C.4.1 General C.4.2 Scope of the post-market surveillance plan C.4.3 Objective of the post-market surveillance plan C.4.4 Responsibilities and authorities C.4.5 Data collection <\/td>\n<\/tr>\n | ||||||
51<\/td>\n | C.4.6 Data analysis C.4.7 Report on data analysis C.4.8 Review of the post-market surveillance plan C.5 Example for large IVD analyser C.5.1 General C.5.2 Scope of the post-market surveillance plan <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | C.5.3 Objective of the post-market surveillance plan C.5.4 Responsibilities and authorities C.5.5 Data collection <\/td>\n<\/tr>\n | ||||||
53<\/td>\n | C.5.6 Data analysis C.5.7 Report on data analysis <\/td>\n<\/tr>\n | ||||||
54<\/td>\n | C.5.8 Review of the post-market surveillance plan <\/td>\n<\/tr>\n | ||||||
55<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" AAMI\/ISO TIR20416:2020, Medical devices-Post-market surveillance for manufacturers<\/b><\/p>\n |